GlobeStar Therapeutics Corporation (GSTC)

GlobeStar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	0	-	0.01	0.01	0.08	0.1
Cash & Short-Term Investments	0	-	0.01	0.01	0.08	0.1
Cash Growth	-	-	6.79%	-92.68%	-18.93%	9.68%
Inventory	-	-	-	-	0	0.04
Prepaid Expenses	0.08	-	0	-	0	0
Total Current Assets	0.08	-	0.01	0.01	0.09	0.14
Property, Plant & Equipment	-	-	-	-	0	0
Total Assets	0.08	-	0.01	0.01	0.09	0.14
Accounts Payable	0.43	0.33	0.38	0.22	0.13	0.14
Accrued Expenses	0.88	0.68	0.61	0.34	0.4	0.41
Short-Term Debt	0.3	0.31	0.14	0.09	-	-
Current Portion of Long-Term Debt	0.03	0.06	0.02	0.02	0.16	0.11
Other Current Liabilities	0.06	0.06	0.06	0.06	0.06	0.17
Total Current Liabilities	1.71	1.43	1.2	0.73	0.75	0.83
Total Liabilities	1.71	1.43	1.2	0.73	0.75	0.83
Common Stock	1.24	1	0.72	0.56	0.44	0.17
Additional Paid-In Capital	17.98	18.02	16.58	15.23	6.12	1.23
Retained Earnings	-21.02	-20.45	-18.5	-17.02	-7.22	-6.67
Comprehensive Income & Other	0.18	-	0.01	0.5	-	-
Total Common Equity	-1.63	-1.43	-1.2	-0.73	-0.66	-5.28
Shareholders' Equity	-1.62	-1.43	-1.19	-0.73	-0.66	-0.69
Total Liabilities & Equity	0.08	-	0.01	0.01	0.09	0.14
Total Debt	0.33	0.37	0.16	0.11	0.16	0.11
Net Cash (Debt)	-0.33	-0.37	-0.15	-0.1	-0.07	-0.01
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Filing Date Shares Outstanding	1,241	1,026	770.36	600.37	445.49	210.3
Total Common Shares Outstanding	1,241	996.12	722.33	561.5	436.22	170.47
Working Capital	-1.62	-1.43	-1.19	-0.73	-0.66	-0.69
Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.03
Tangible Book Value	-1.63	-1.43	-1.2	-0.73	-0.66	-5.28
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.03

Updated Oct 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.